244 related articles for article (PubMed ID: 29908243)
21. Cisplatin ototoxicity involves cytokines and STAT6 signaling network.
Kim HJ; Oh GS; Lee JH; Lyu AR; Ji HM; Lee SH; Song J; Park SJ; You YO; Sul JD; Park C; Chung SY; Moon SK; Lim DJ; So HS; Park R
Cell Res; 2011 Jun; 21(6):944-56. PubMed ID: 21321603
[TBL] [Abstract][Full Text] [Related]
22. The Protective Effect of Cortexin on Cisplatin-Induced Ototoxicity.
Eroğlu O; Karlıdağ T; Kuloğlu T; Keleş E; Kaygusuz İ; Yalçın Ş
J Int Adv Otol; 2018 Apr; 14(1):27-33. PubMed ID: 29092803
[TBL] [Abstract][Full Text] [Related]
23. KL1333, a derivative of β-lapachone, protects against cisplatin-induced ototoxicity in mouse cochlear cultures.
Lee HS; Kim YR; Lee IK; Kim UK; Baek JI; Lee KY
Biomed Pharmacother; 2020 Jun; 126():110068. PubMed ID: 32203888
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the effects of lipoic acid and glutathione against cisplatin-induced ototoxicity in auditory cells.
Koo DY; Lee SH; Lee S; Chang J; Jung HH; Im GJ
Int J Pediatr Otorhinolaryngol; 2016 Dec; 91():30-36. PubMed ID: 27863638
[TBL] [Abstract][Full Text] [Related]
25. Protective Effect of Avenanthramide-C on Auditory Hair Cells against Oxidative Stress, Inflammatory Cytokines, and DNA Damage in Cisplatin-Induced Ototoxicity.
Umugire A; Nam YS; Nam YE; Choi YM; Choi SM; Lee S; Cho JH; Cho HH
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769271
[TBL] [Abstract][Full Text] [Related]
26. Ebselen attenuates cisplatin-induced ROS generation through Nrf2 activation in auditory cells.
Kim SJ; Park C; Han AL; Youn MJ; Lee JH; Kim Y; Kim ES; Kim HJ; Kim JK; Lee HK; Chung SY; So H; Park R
Hear Res; 2009 May; 251(1-2):70-82. PubMed ID: 19286452
[TBL] [Abstract][Full Text] [Related]
27. Ginkgolide B protects against cisplatin-induced ototoxicity: enhancement of Akt-Nrf2-HO-1 signaling and reduction of NADPH oxidase.
Ma W; Hu J; Cheng Y; Wang J; Zhang X; Xu M
Cancer Chemother Pharmacol; 2015 May; 75(5):949-59. PubMed ID: 25749575
[TBL] [Abstract][Full Text] [Related]
28. miR214-regulated p53-NOX4/p66shc pathway plays a crucial role in the protective effect of Ginkgolide B against cisplatin-induced cytotoxicity in HEI-OC1 cells.
Ma W; Li J; Hu J; Cheng Y; Wang J; Zhang X; Xu M
Chem Biol Interact; 2016 Feb; 245():72-81. PubMed ID: 26768586
[TBL] [Abstract][Full Text] [Related]
29. Dose dependent protection by lipoic acid against cisplatin-induced ototoxicity in rats: antioxidant defense system.
Rybak LP; Husain K; Whitworth C; Somani SM
Toxicol Sci; 1999 Feb; 47(2):195-202. PubMed ID: 10220857
[TBL] [Abstract][Full Text] [Related]
30. The effects of the antioxidant α-tocopherol succinate on cisplatin-induced ototoxicity in HEI-OC1 auditory cells.
Kim SK; Im GJ; An YS; Lee SH; Jung HH; Park SY
Int J Pediatr Otorhinolaryngol; 2016 Jul; 86():9-14. PubMed ID: 27260571
[TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo effects of lutein against cisplatin-induced ototoxicity.
Roldán-Fidalgo A; Martín Saldaña S; Trinidad A; Olmedilla-Alonso B; Rodríguez-Valiente A; García-Berrocal JR; Ramírez-Camacho R
Exp Toxicol Pathol; 2016 Apr; 68(4):197-204. PubMed ID: 26850526
[TBL] [Abstract][Full Text] [Related]
32. Targeting nitrative stress for attenuating cisplatin-induced downregulation of cochlear LIM domain only 4 and ototoxicity.
Jamesdaniel S; Rathinam R; Neumann WL
Redox Biol; 2016 Dec; 10():257-265. PubMed ID: 27821327
[TBL] [Abstract][Full Text] [Related]
33. Isotretinoin's action against cisplatin-induced ototoxicity in rats.
Alan MA; Eryılmaz MA; Kaymaz F; Suzer A; Arıcıgil M
Pak J Pharm Sci; 2018 Nov; 31(6 (Supplementary):2579-2584. PubMed ID: 30587464
[TBL] [Abstract][Full Text] [Related]
34. Cisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents.
Schweitzer VG
Laryngoscope; 1993 Apr; 103(4 Pt 2):1-52. PubMed ID: 8464301
[TBL] [Abstract][Full Text] [Related]
35. AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity.
Cooper LB; Chan DK; Roediger FC; Shaffer BR; Fraser JF; Musatov S; Selesnick SH; Kaplitt MG
Otol Neurotol; 2006 Jun; 27(4):484-90. PubMed ID: 16791039
[TBL] [Abstract][Full Text] [Related]
36. Protective effects of 1,2,3-triazole derivative KPR-A020 against cisplatin-induced ototoxicity in murine cochlear cultures.
Kim YR; Jung DJ; Oh SK; Lee T; Lee IK; Lee KY; Kim UK
Int J Pediatr Otorhinolaryngol; 2017 May; 96():59-64. PubMed ID: 28390615
[TBL] [Abstract][Full Text] [Related]
37. Selective GSK-3beta inhibitors attenuate the cisplatin-induced cytotoxicity of auditory cells.
Park HJ; Kim HJ; Bae GS; Seo SW; Kim DY; Jung WS; Kim MS; Song MY; Kim EK; Kwon KB; Hwang SY; Song HJ; Park CS; Park RK; Chong MS; Park SJ
Hear Res; 2009 Nov; 257(1-2):53-62. PubMed ID: 19666099
[TBL] [Abstract][Full Text] [Related]
38. The comparative effects of sodium thiosulfate, diethyldithiocarbamate, fosfomycin and WR-2721 on ameliorating cisplatin-induced ototoxicity.
Church MW; Kaltenbach JA; Blakley BW; Burgio DL
Hear Res; 1995 Jun; 86(1-2):195-203. PubMed ID: 8567417
[TBL] [Abstract][Full Text] [Related]
39. Ototoxicity caused by cisplatin is ameliorated by melatonin and other antioxidants.
Lopez-Gonzalez MA; Guerrero JM; Rojas F; Delgado F
J Pineal Res; 2000 Mar; 28(2):73-80. PubMed ID: 10709968
[TBL] [Abstract][Full Text] [Related]
40. Tauroursodeoxycholic acid attenuates cisplatin-induced ototoxicity by inhibiting the accumulation and aggregation of unfolded or misfolded proteins in the endoplasmic reticulum.
Wen Y; Zong S; Liu T; Du P; Li H; Xiao H
Toxicology; 2021 Apr; 453():152736. PubMed ID: 33631298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
